|
1
|
Shin A, Kim J and Park S: Gastric cancer
epidemiology in Korea. J Gastric Cancer. 11:135–140. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rivas-Ortiz CI, Lopez-Vidal Y,
Arredondo-Hernandez LJR and Castillo-Rojas G: Genetic alterations
in gastric cancer associated with helicobacter pylori infection.
Front Med (Lausanne). 4:472017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ilson DH: Advances in the treatment of
gastric cancer. Curr Opin Gastroenterol. 34:465–468. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang S and Yuan L: Predictive biomarkers
for targeted and cytotoxic agents in gastric cancer for
personalized medicine. Biosci Trends. 10:171–180. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
An W, Lai H, Zhang Y, Liu M, Lin X and Cao
S: Apoptotic pathway as the therapeutic target for anticancer
traditional chinese medicines. Front Pharmacol. 10:7582019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pavet V, Portal MM, Moulin JC, Herbrecht R
and Gronemeyer H: Towards novel paradigms for cancer therapy.
Oncogene. 30:1–20. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alessandro R, Fontana S, Kohn E and De Leo
G: Proteomic strategies and their application in cancer research.
Tumori. 91:447–455. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ludwig JA and Weinstein JN: Biomarkers in
cancer staging, prognosis and treatment selection. Nat Rev Cancer.
5:845–856. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hanash SM, Madoz-Gurpide J and Misek DE:
Identification of novel targets for cancer therapy using expression
proteomics. Leukemia. 16:478–485. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang J, Chen L, Kong X, Huang T and Cai
YD: Analysis of tumor suppressor genes based on gene ontology and
the KEGG pathway. PLoS One. 9:e1072022014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee HH, Lim CA, Cheong YT, Singh M and Gam
LH: Comparison of protein expression profiles of different stages
of lymph nodes metastasis in breast cancer. Int J Biol Sci.
8:353–362. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Agbarya A, Ruimi N, Epelbaum R, Ben-Arye E
and Mahajna J: Natural products as potential cancer therapy
enhancers: A preclinical update. SAGE Open Med.
2:20503121145469242014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chahar MK, Sharma N, Dobhal MP and Joshi
YC: Flavonoids: A versatile source of anticancer drugs. Pharmacogn
Rev. 5:1–12. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee HJ, Venkatarame Gowda Saralamma V, Kim
SM, Ha SE, Raha S, Lee WS, Kim EH, Lee SJ, Heo JD and Kim GS:
Pectolinarigenin induced cell cycle arrest, autophagy, and
apoptosis in gastric cancer cell via PI3K/AKT/mTOR signaling
pathway. Nutrients. 10:10432018. View Article : Google Scholar
|
|
15
|
Sang Eun H, Seong Min K, Ho Jeong L,
Vetrivel P, Venkatarame Gowda Saralamma V, Jeong Doo H, Eun Hee K,
Sang Joon L and Gon Sup K: Scutellarein induces fas-mediated
extrinsic apoptosis and G2/M cell cycle arrest in Hep3B
hepatocellular carcinoma cells. Nutrients. 11:2632019. View Article : Google Scholar
|
|
16
|
Gowda Saralamma VV, Lee HJ, Raha S, Lee
WS, Kim EH, Lee SJ, Heo JD, Won C, Kang CK and Kim GS: Inhibition
of IAP's and activation of p53 leads to caspase-dependent apoptosis
in gastric cancer cells treated with scutellarein. Oncotarget.
9:5993–6006. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee HJ, Venkatarame Gowda Saralamma V, Kim
SM, Ha SE, Vetrivel P, Kim EH, Lee SJ, Heo JD, Rampogu S, Lee KW
and Kim GS: Comparative proteomic profiling of tumor-associated
proteins in human gastric cancer cells treated with
pectolinarigenin. Nutrients. 10:15962018. View Article : Google Scholar
|
|
18
|
Swain M and Ross NW: A silver stain
protocol for proteins yielding high resolution and transparent
background in sodium dodecyl sulfate-polyacrylamide gels.
Electrophoresis. 16:948–951. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shevchenko A, Wilm M, Vorm O and Mann M:
Mass spectrometric sequencing of proteins silver-stained
polyacrylamide gels. Anal Chem. 68:850–858. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Baker PR and Chalkley RJ: MS-viewer: A
web-based spectral viewer for proteomics results. Mol Cell
Proteomics. 13:1392–1396. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Halgren TA, Murphy RB, Friesner RA, Beard
HS, Frye LL, Pollard WT and Banks JL: Glide: A new approach for
rapid, accurate docking and scoring. 2. Enrichment factors in
database screening. J Med Chem. 47:1750–1759. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tabas-Madrid D, Nogales-Cadenas R and
Pascual-Montano A: GeneCodis3: A non-redundant and modular
enrichment analysis tool for functional genomics. Nucleic Acids
Res. 40:W478–W483. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thomas PD, Campbell MJ, Kejariwal A, Mi H,
Karlak B, Daverman R, Diemer K, Muruganujan A and Narechania A:
PANTHER: A library of protein families and subfamilies indexed by
function. Genome Res. 13:2129–2141. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Starovoytov ON, Liu Y, Tan L and Yang S:
Effects of the hydroxyl group on phenyl based ligand/ERRγ protein
binding. Chem Res Toxicol. 27:1371–1379. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen KF, Liu CY, Lin YC, Yu HC, Liu TH,
Hou DR, Chen PJ and Cheng AL: CIP2A mediates effects of bortezomib
on phospho-Akt and apoptosis in hepatocellular carcinoma cells.
Oncogene. 29:6257–6266. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gao F, Xu T, Wang X, Zhong S, Chen S,
Zhang M, Zhang X, Shen Y, Wang X, Xu C and Shen Z: CIP2A mediates
fibronectin-induced bladder cancer cell proliferation by
stabilizing beta-catenin. J Exp Clin Cancer Res. 36:702017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Feather SA, Woolf AS, Donnai D, Malcolm S
and Winter RM: The oral-facial-digital syndrome type 1 (OFD1), a
cause of polycystic kidney disease and associated malformations,
maps to Xp22.2-Xp22.3. Hum Mol Genet. 6:1163–1167. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wee S, Wiederschain D, Maira SM, Loo A,
Miller C, deBeaumont R, Stegmeier F, Yao YM and Lengauer C:
PTEN-deficient cancers depend on PIK3CB. Proc Natl Acad Sci USA.
105:13057–13062. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Riquelme I, Tapia O, Leal P, Sandoval A,
Varga MG, Letelier P, Buchegger K, Bizama C, Espinoza JA and Peek
RM: miR-101-2, miR-125b-2 and miR-451a act as potential tumor
suppressors in gastric cancer through regulation of the
PI3K/AKT/mTOR pathway. Cell Oncol (Dordr). 39:23–33. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Martini M, De Santis MC, Braccini L,
Gulluni F and Hirsch E: PI3K/AKT signaling pathway and cancer: An
updated review. Ann Med. 46:372–383. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rice MA, Ishteiwy RA, Magani F, Udayakumar
T, Reiner T, Yates TJ, Miller P, Perez-Stable C, Rai P, Verdun R,
et al: The microRNA-23b/-27b cluster suppresses prostate cancer
metastasis via Huntingtin-interacting protein 1-related. Oncogene.
35:4752–4761. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ai J, Jin T, Yang L, Wei Q, Yang Y, Li H
and Zhu Y: Vinculin and filamin-C are two potential prognostic
biomarkers and therapeutic targets for prostate cancer cell
migration. Oncotarget. 8:82430–82436. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rubashkin MG, Cassereau L, Bainer R,
DuFort CC, Yui Y, Ou G, Paszek MJ, Davidson MW, Chen YY and Weaver
VM: Force engages vinculin and promotes tumor progression by
enhancing PI3K activation of phosphatidylinositol
(3,4,5)-triphosphate. Cancer Res. 74:4597–4611. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu W, Zhao Y and Wu J: Gene expression
profile analysis of the progression of carotid atherosclerotic
plaques. Mol Med Rep. 17:5789–5795. 2018.PubMed/NCBI
|
|
36
|
Grassilli S, Brugnoli F, Lattanzio R,
Marchisio M, Perracchio L, Piantelli M, Bavelloni A, Capitani S and
Bertagnolo V: Vav1 downmodulates Akt in different breast cancer
subtypes: A new promising chance to improve breast cancer outcome.
Mol Oncol. 12:1012–1025. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Davenport JW, Fernandes ER, Harris LD,
Neale GA and Goorha R: The mouse mitotic checkpoint gene bub1b, a
novel bub1 family member, is expressed in a cell cycle-dependent
manner. Genomics. 55:113–117. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ma Q, Liu Y, Shang L, Yu J and Qu Q: The
FOXM1/BUB1B signaling pathway is essential for the tumorigenicity
and radioresistance of glioblastoma. Oncol Rep. 38:3367–3375.
2017.PubMed/NCBI
|
|
39
|
Fort L, Batista JM, Thomason PA, Spence
HJ, Whitelaw JA, Tweedy L, Greaves J, Martin KJ, Anderson KI, Brown
P, et al: Fam49/CYRI interacts with Rac1 and locally suppresses
protrusions. Nat Cell Biol. 20:1159–1171. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sakata M, Kitamura YH, Sakuraba K, Goto T,
Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y and
Hibi K: Methylation of HACE1 in gastric carcinoma. Anticancer Res.
29:2231–2233. 2009.PubMed/NCBI
|
|
41
|
Sanaei M, Kavoosi F, Roustazadeh A and
Golestan F: Effect of genistein in comparison with trichostatin a
on reactivation of dnmts genes in hepatocellular carcinoma. J Clin
Transl Hepatol. 6:141–146. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ravichandran K and Edelstein CL:
Polycystic kidney disease: A case of suppressed autophagy? Semin
Nephrol. 34:27–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tang Z, Lin MG, Stowe TR, Chen S, Zhu M,
Stearns T, Franco B and Zhong Q: Autophagy promotes primary
ciliogenesis by removing OFD1 from centriolar satellites. Nature.
502:254–257. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kent OA, Sandi MJ, Burston HE, Brown KR
and Rottapel R: An oncogenic KRAS transcription program activates
the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic
cancer. Oncotarget. 8:4484–4500. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
West AC, Tang K, Tye H, Yu L, Deng N,
Najdovska M, Lin SJ, Balic JJ, Okochi-Takada E, McGuirk P, et al:
Identification of a TLR2-regulated gene signature associated with
tumor cell growth in gastric cancer. Oncogene. 36:5134–5144. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
de Oliveira JG and Silva AE: Polymorphisms
of the TLR2 and TLR4 genes are associated with risk of gastric
cancer in a Brazilian population. World J Gastroenterol.
18:1235–1242. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li L and Ma L: Upregulation of miR-582-5p
regulates cell proliferation and apoptosis by targeting AKT3 in
human endometrial carcinoma. Saudi J Biol Sci. 25:965–970. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Turner KM, Sun Y, Ji P, Granberg KJ,
Bernard B, Hu L, Cogdell DE, Zhou X, Yli-Harja O, Nykter M, et al:
Genomically amplified Akt3 activates DNA repair pathway and
promotes glioma progression. Proc Natl Acad Sci USA. 112:3421–3426.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jin Y, Tao LP, Yao SC, Huang QK, Chen ZF,
Sun YJ and Jin SQ: MicroRNA-582-5p suppressed gastric cancer cell
proliferation via targeting AKT3. Eur Rev Med Pharmacol Sci.
21:5112–5120. 2017.PubMed/NCBI
|
|
50
|
Li W, Ge Z, Liu C, Liu Z, Björkholm M, Jia
J and Xu D: CIP2A is overexpressed in gastric cancer and its
depletion leads to impaired clonogenicity, senescence, or
differentiation of tumor cells. Clin Cancer Res. 14:3722–3728.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Niemela M, Kauko O, Sihto H, Mpindi JP,
Nicorici D, Pernilä P, Kallioniemi OP, Joensuu H, Hautaniemi S and
Westermarck J: CIP2A signature reveals the MYC dependency of
CIP2A-regulated phenotypes and its clinical association with breast
cancer subtypes. Oncogene. 31:4266–4278. 2012. View Article : Google Scholar : PubMed/NCBI
|
